# Early phase 1 breast cancer trials recruiting: 31 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 31 trials in early phase 1 for breast cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Early phase 1 breast cancer trials: 31 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/early-phase-1/breast-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 31
- Recruiting or not yet: 31
- Read on: November 19, 2026

## Trials

The 25 newest of 31, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 24, 2026 | NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | Lumina Pharmaceuticals Inc | Early phase 1 | Not yet recruiting | Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781852) |
| June 26, 2026 | NCT07671092 | Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC | RayzeBio, Inc. | Early phase 1 | Recruiting | Metastatic Urothelial Carcinoma, Breast Cancer, TNBC - Triple-Negative Breast Cancer, Hormone Receptor Positive HER-2... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07671092) |
| June 10, 2026 | NCT07639970 | Evaluation of \[⁶⁸Ga/¹⁷⁷Lu\]HT547: Safety, Biodistribution, and Dosimetry in Solid Tumors | Sponsor not shown (see the record) | Early phase 1 | Not yet recruiting | Breast Cancer, Head and Neck Cancer (H&N), Pancreatic Cancer, Glioma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639970) |
| May 27, 2026 | NCT07608848 | First-in-human Diagnostic Imaging Profile of the Theranostic Pair \[68Ga\]Ga-DOTA-STR-17126 and Low Dose \[177Lu\] Lu-DOTA-STR-17126 in... | Integrated Haematology and Oncology Network | Early phase 1 | Recruiting | Metastatic Breast Cancer, Metastatic Prostate Cancer, GRPR-Targeted Molecular Imaging, Theranostic... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07608848) |
| March 9, 2026 | NCT07459283 | The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors | FindCure Biosciences (ZhongShan) Co., Ltd. | Early phase 1 | Recruiting | Maligant Solid Tumor, Head & Neck Cancer, Thyroid Cancer, Lung Cancer - Non Small Cell Squamous, Breast Cancer, Sarcoma | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07459283) |
| March 3, 2026 | NCT07446686 | Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer | Guizhou Provincial People's Hospital | Early phase 1 | Not yet recruiting | Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07446686) |
| January 6, 2026 | NCT07319195 | Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC) | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Breast Cancer | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07319195) |
| November 19, 2025 | NCT07236177 | B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the... | Poitiers University Hospital | Early phase 1 | Recruiting | Breast Cancer, Pancreatic Cancer, Pulmonary Cancer, Volatile Organic Compound, Glycosidase Activity, Probes, Tumor... | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07236177) |
| February 14, 2025 | NCT06828588 | Pilot Study of \[68Ga\]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy | Vanderbilt-Ingram Cancer Center | Early phase 1 | Recruiting | Locally Advanced Cancer, Metastatic Cancer, HER2, HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06828588) |
| January 1, 2025 | NCT06756295 | A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR) | Sponsor not shown (see the record) | Early phase 1 | Not yet recruiting | Breast Cancer, Colorectal Cancer, Melanoma, Lung Cancer | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06756295) |
| November 21, 2024 | NCT06700070 | A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid... | Pure Biologics S.A. | Early phase 1 | Recruiting | Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult, Triple Negative Breast Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06700070) |
| October 17, 2024 | NCT06645808 | PET-imaging of Two Vartumabs in Patients With Solid Tumors | Var2 Pharmaceuticals | Early phase 1 | Recruiting | Solid Tumor, Colon Carcinoma, Rectal Carcinoma, Osteosarcoma, Chondrosarcoma, Lung Carcinoma, Head and Neck Squamous... | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06645808) |
| October 15, 2024 | NCT06637306 | Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Locally Advanced Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06637306) |
| September 19, 2024 | NCT06586047 | Breast Cancer PSMA PET | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Triple Negative Breast Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06586047) |
| May 30, 2024 | NCT06435351 | Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy | H. Lee Moffitt Cancer Center and Research Institute | Early phase 1 | Recruiting | Breast Cancer, Triple Negative Breast Cancer | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06435351) |
| May 13, 2024 | NCT06411678 | Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer | Peking Union Medical College Hospital | Early phase 1 | Recruiting | Breast Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06411678) |
| March 12, 2024 | NCT06305962 | 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors | Radiopharm Theranostics, Ltd | Early phase 1 | Recruiting | PDL1 Gene Mutation, Non Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), TNBC, Triple Negative Breast Cancer... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06305962) |
| January 23, 2024 | NCT06220214 | Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Breast Cancer, Locally Advanced Breast Cancer, Neoadjuvant Chemotherapy, HER2-positive Breast Cancer, Triple Negative... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06220214) |
| November 8, 2023 | NCT06123286 | Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06123286) |
| August 23, 2023 | NCT06008275 | Neratinib in Combination With Ruxolitinib in Patients With mTNBC | Baylor Research Institute | Early phase 1 | Recruiting | Metastatic Triple-Negative Breast Carcinoma, Breast Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06008275) |
| June 27, 2023 | NCT05921253 | Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy | University of Oklahoma | Early phase 1 | Recruiting | Breast Cancer, Lymphoma | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05921253) |
| March 3, 2023 | NCT05753657 | A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With... | Rambam Health Care Campus | Early phase 1 | Recruiting | Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05753657) |
| January 30, 2023 | NCT05704283 | 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer | Mayo Clinic | Early phase 1 | Recruiting | Breast Carcinoma | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05704283) |
| December 21, 2022 | NCT05659797 | FES BPET-DBT in Newly Diagnosed Breast Cancer | Abramson Cancer Center at Penn Medicine | Early phase 1 | Recruiting | Breast Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05659797) |
| September 22, 2022 | NCT05549024 | 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients | Peking Union Medical College Hospital | Early phase 1 | Recruiting | Breast Cancer, Prostate Cancer, Brain Tumor, PET/CT Imaging | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05549024) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Alabama at Birmingham | 2 |
| Baylor Research Institute | 2 |
| Peking Union Medical College Hospital | 2 |
| RayzeBio, Inc. | 1 |
| FindCure Biosciences (ZhongShan) Co., Ltd. | 1 |
| Var2 Pharmaceuticals | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Radiopharm Theranostics, Ltd | 1 |
| Guizhou Provincial People's Hospital | 1 |
| Mayo Clinic | 1 |
| Poitiers University Hospital | 1 |
| Pure Biologics S.A. | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
| University of Utah | 1 |
| Lumina Pharmaceuticals Inc | 1 |
| The Affiliated Hospital of Qingdao University | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| University of Oklahoma | 1 |
| Integrated Haematology and Oncology Network | 1 |
| Rambam Health Care Campus | 1 |
| Shanghai Juncell Therapeutics | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 17 |
| China | 5 |
| Australia | 3 |
| New Zealand | 1 |
| South Africa | 1 |
| Netherlands | 1 |
| France | 1 |
| Israel | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Home insurance agencies in the United States](https://specstream.ai/data/businesses/home-insurance-agencies/united-states)
- [Bistros in the United States](https://specstream.ai/data/businesses/bistros/united-states)
- [Scientific laboratories in the United States](https://specstream.ai/data/businesses/scientific-laboratories/united-states)
- [Immigration law firms in the United States](https://specstream.ai/data/businesses/immigration-law-firms/united-states)
- [Business law firms in the United States](https://specstream.ai/data/businesses/business-law-firms/united-states)
- [Solar installers in the United States](https://specstream.ai/data/businesses/solar-installers/united-states)
